348 related articles for article (PubMed ID: 31678302)
21. Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm.
Nakanuma Y; Kakuda Y; Uesaka K
Gut Liver; 2019 Nov; 13(6):617-627. PubMed ID: 30982236
[TBL] [Abstract][Full Text] [Related]
22. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
[TBL] [Abstract][Full Text] [Related]
23. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects.
Lim JH; Zen Y; Jang KT; Kim YK; Nakanuma Y
AJR Am J Roentgenol; 2011 Nov; 197(5):1111-20. PubMed ID: 22021503
[TBL] [Abstract][Full Text] [Related]
24. Hilar cholangiocarcinoma is pathologically similar to pancreatic duct adenocarcinoma: suggestions of similar background and development.
Nakanuma Y; Sato Y
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):441-7. PubMed ID: 24446421
[TBL] [Abstract][Full Text] [Related]
25. Difficult Diagnostic Problems in Pancreatobiliary Neoplasia.
Bledsoe JR; Shinagare SA; Deshpande V
Arch Pathol Lab Med; 2015 Jul; 139(7):848-57. PubMed ID: 26125425
[TBL] [Abstract][Full Text] [Related]
26. Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
Singhi AD; George B; Greenbowe JR; Chung J; Suh J; Maitra A; Klempner SJ; Hendifar A; Milind JM; Golan T; Brand RE; Zureikat AH; Roy S; Schrock AB; Miller VA; Ross JS; Ali SM; Bahary N
Gastroenterology; 2019 Jun; 156(8):2242-2253.e4. PubMed ID: 30836094
[TBL] [Abstract][Full Text] [Related]
27. Intraductal neoplasms of the pancreatobiliary tract: navigating the alphabet.
Xue Y; Basturk O
Histopathology; 2023 Oct; 83(4):499-508. PubMed ID: 37455382
[TBL] [Abstract][Full Text] [Related]
28. Precursor Lesions of Pancreatic Cancer.
Kim JY; Hong SM
Oncol Res Treat; 2018; 41(10):603-610. PubMed ID: 30269131
[TBL] [Abstract][Full Text] [Related]
29. Pancreatobiliary-type intraductal papillary mucinous neoplasm of the pancreas may have 2 subtypes with distinct clinicopathologic and genetic features.
Shimizu T; Akita M; Sofue K; Toyama H; Itoh T; Fukumoto T; Zen Y
Hum Pathol; 2019 Sep; 91():26-35. PubMed ID: 31175918
[TBL] [Abstract][Full Text] [Related]
30. Pathologic classification of cholangiocarcinoma: New concepts.
Nakanuma Y; Kakuda Y
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428
[TBL] [Abstract][Full Text] [Related]
31. CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype.
Mattiolo P; Hong SM; Paolino G; Rusev BC; Marchegiani G; Salvia R; Andrianello S; Capelli P; Piccoli P; Parolini C; Scarpa A; Lawlor RT; Luchini C
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806726
[TBL] [Abstract][Full Text] [Related]
32. Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas.
Wang T; Askan G; Adsay V; Allen P; Jarnagin WR; Memis B; Sigel C; Seven IE; Klimstra DS; Basturk O
Am J Surg Pathol; 2019 May; 43(5):656-661. PubMed ID: 30986801
[TBL] [Abstract][Full Text] [Related]
33. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.
Gandou C; Harada K; Sato Y; Igarashi S; Sasaki M; Ikeda H; Nakanuma Y
Hum Pathol; 2013 May; 44(5):811-21. PubMed ID: 23134772
[TBL] [Abstract][Full Text] [Related]
34. [Intraductal papillary neoplasms of intrahepatic bile duct: a clinicopathologic study of 25 cases].
Chang XY; Li J; Ren XY; Zhou WX; Chen J
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):243-7. PubMed ID: 27033387
[TBL] [Abstract][Full Text] [Related]
35. Clinical assessment of the GNAS mutation status in patients with intraductal papillary mucinous neoplasm of the pancreas.
Ohtsuka T; Tomosugi T; Kimura R; Nakamura S; Miyasaka Y; Nakata K; Mori Y; Morita M; Torata N; Shindo K; Ohuchida K; Nakamura M
Surg Today; 2019 Nov; 49(11):887-893. PubMed ID: 30879148
[TBL] [Abstract][Full Text] [Related]
36. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.
Abraham SC; Lee JH; Hruban RH; Argani P; Furth EE; Wu TT
Hum Pathol; 2003 Sep; 34(9):902-10. PubMed ID: 14562286
[TBL] [Abstract][Full Text] [Related]
37. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes.
Aoki Y; Mizuma M; Hata T; Aoki T; Omori Y; Ono Y; Mizukami Y; Unno M; Furukawa T
J Pathol; 2020 May; 251(1):38-48. PubMed ID: 32100878
[TBL] [Abstract][Full Text] [Related]
38. Intraductal oncocytic papillary neoplasm of the bile duct: clinicopathologic and immunohistochemical characteristics of 6 cases.
Tanaka M; Fukushima N; Noda N; Shibahara J; Kokudo N; Fukayama M
Hum Pathol; 2009 Nov; 40(11):1543-52. PubMed ID: 19540556
[TBL] [Abstract][Full Text] [Related]
39. [Synchronous malignant intraductal papillary mucinous neoplasms of the bile duct and pancreas requiring left hepatectomy and total pancreatectomy].
Moon DB; Lee SG; Jung DH; Park GC; Park YH; Park HW; Kim MH; Lee SK; Yu ES; Kim JH
Korean J Gastroenterol; 2014 Feb; 63(2):129-33. PubMed ID: 24561701
[TBL] [Abstract][Full Text] [Related]
40. SPARC expression in desmoplastic and non desmoplastic pancreatic carcinoma and cholangiocarcinoma.
Khetan K; Baloda V; Sahoo RK; Vishnubhathla S; Yadav R; Saraya A; Sharma A; Gupta SD; Das P
Pathol Res Pract; 2019 Dec; 215(12):152685. PubMed ID: 31727501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
